A-MAV™ Anterior Motion Segment Replacement
A Prospective, Non-Randomized Pilot Clinical Investigation of the A-MAV™ Anterior Motion Segment Replacement in Patients With Lumbar Degenerative Disc Disease
Sponsor: Medtronic Spinal and Biologics
This NA trial investigates Spinal Diseases and is currently completed. Medtronic Spinal and Biologics leads this study, which shows 8 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2022 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Apr 2022 [monthly]
Completed NA
-
Oct 2018 — Jan 2021 [monthly]
Completed NA
Phase: PHASE1 → NA
▶ Show 3 earlier versions
-
Jun 2018 — Oct 2018 [monthly]
Completed PHASE1
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE1
First recorded
Dec 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic Spinal and Biologics
For direct contact, visit the study record on ClinicalTrials.gov .